BMO Capital lowered the firm’s price target on Bill (BILL) to $54 from $56 and keeps a Market Perform rating on the shares. The company’s Q1 results were “good” but not great as revenue and profit upside were not too dissimilar from recent trends, the analyst tells investors in a research note. BMO adds however that evidence of improvement could come into greater clarity later in the fiscal year.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BILL:
- Bill price target lowered to $60 from $65 at UBS
- Bill price target raised to $60 from $55 at JPMorgan
- Bill price target lowered to $48 from $56 at Keefe Bruyette
- Bill.com: Resilient Growth and Emerging Innovations Drive Buy Rating
- Hold Rating on Bill.com Holdings Amid Uncertain Monetization and Competitive Challenges